CD79A and irritable bowel syndrome: Potential cost saving of applying our approach, including both tTG IgA and plain abdominal radiograph would have been 73.4% for the 15 patients with IBS-C; 87% for the 8 IBS-D patients and 76.8% for the 14 IBS-M patients.